A review of local anesthetic cardiotoxicity and treatment with lipid emulsion

Local and Regional Anesthesia

Volumn 3, Issue 1, 2010, Pages 11-19

  Bourne, Emma ^a   Wright, Christine ^a   Royse, Colin ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiac toxicity; Cardiovascular collapse; Lipid emulsion; Local anesthetic

Indexed keywords

ADRENALIN; BUPIVACAINE; INFUSION FLUID; INTRALIPID; LEVOBUPIVACAINE; LIPID EMULSION; LOCAL ANESTHETIC AGENT; MEDIALIPIDE; PARACETAMOL; PRAZOSIN; ROPIVACAINE; STRUCTOLIPID; UNCLASSIFIED DRUG; VASOPRESSIN;

ANESTHESIA COMPLICATION; ANESTHESIA MECHANISM; BLOOD PRESSURE; CARDIOGENIC SHOCK; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMA; CONTINUOUS INFUSION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FATALITY; DRUG MEGADOSE; DRUG OVERDOSE; DRUG TOLERABILITY; DRUG TRANSFORMATION; HEART ARREST; HEART ARRHYTHMIA; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE CONDUCTION; HUMAN; HYPOTENSION; LOCAL ANESTHESIA; LOW DRUG DOSE; NONHUMAN; PR INTERVAL; QRS COMPLEX; REGIONAL ANESTHESIA; RESUSCITATION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SKIN TINGLING; TACHYCARDIA; TINNITUS; TONIC CLONIC SEIZURE; TREATMENT DURATION; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 77953421698     PISSN: None     EISSN: 11787112     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem. 2001;1(3): 175-182.
2. Albright G. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology. 1979;51:285-287.
3. Trachez MM, Zapata-Sudo G, Moreira OR, Chedid NG, Russo VF, Russo EM, et al. Motor nerve blockade potency and toxicity of non-racemic bupivacaine in rats. Acta Anaesthesiol Scand. 2005;49(1):66-71.
4. Zapata-Sudo G, Trachez MM, Sudo RT, Nelson TE. Is comparative cardiotoxicity of S(-) and R(+) bupivacaine related to enantiomer-selective inhibition of L-type Ca(2+) channels? Anesth Analg. 2001;92(2): 496-501.
5. Ritchie JM, Ritchie B, Greengard P. The active structure of local anesthetics. J Pharmacol Exp Ther. 1965;150(1):152-159.
6. Valenzuela C, Delpon E, Franqueza L, Gay P, Snyders DJ, Tamargo J. Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. Anesthesiology. 1997;86(3):718-728.
7. 2+ channels? Br J Anaesth. 1997;78(2):185-188.
8. Felice K, Schumann H. Intravenous lipid emulsion for local anesthetic toxicity: a review of the literature. J Med Toxicol. 2008;4(3):184-191.
9. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004;29(6):564-575.
10. Oda Y, Furuichi K, Tanaka K, Hiroi T, Imaoka S, Asada A, et al. Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology. 1995;82(1):214-220.
11. Copeland SE, Ladd LA, Gu XQ, Mather LE. The effects of general anesthesia on whole body and regional pharmacokinetics of local anesthetics at toxic doses. Anesth Analg. 2008;106(5):1440-1449.
12. Royse CF, Liew DF, Wright CE, Royse AG, Angus JA. Persistent depression of contractility and vasodilation with propofol but not with sevoflurane or desflurane in rabbits. Anesthesiology. 2008;108(1): 87-93.
13. Copeland SE, Ladd LA, Gu XQ, Mather LE. The effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics. Anesth Analg. 2008;106(5):1429-1439.
14. de La Coussaye JE, Eledjam JJ, Bruelle P, Lefrant JY, Bassoul B, Peray PA, et al. Mechanisms of the putative cardioprotective effect of hexamethonium in anesthetized dogs given a large dose of bupivacaine. Anesthesiology. 1994;80(3):595-605.
15. Lefrant JY, de La Coussaye JE, Ripart J, Muller L, Lalourcey L, Peray PA, et al. The comparative electrophysiologic and hemodynamic effects of a large dose of ropivacaine and bupivacaine in anesthetized and ventilated piglets. Anesth Analg. 2001;93(6):1598-1605.
16. Royse CF, Royse AG. The myocardial and vascular effects of bupiva-caine, levobupivacaine, and ropivacaine using pressure volume loops. Anesth Analg. 2005;101(3):679-687.
17. Chang KS, Morrow DR, Kuzume K, Andresen MC. Bupivacaine inhibits baroreflex control of heart rate in conscious rats. Anesthesiology. 2000; 92(1):197-207.
18. Watanabe Y, Dohi S, Iida H, Ishiyama T. The effects of bupivacaine and ropivacaine on baroreflex sensitivity with or without respiratory acidosis and alkalosis in rats. Anesth Analg. 1997;84(2): 398-404.
19. Pickering AE, Waki H, Headley PM, Paton JF. Investigation of systemic bupivacaine toxicity using the in situ perfused working heart-brainstem preparation of the rat. Anesthesiology. 2002;97(6):1550-1556.
20. Bardsley H, Gristwood R, Baker H, Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol. 1998;46(3):245-249.
21. Knudsen K, Beckman Suurkula M, Blomberg S, Sjovall J, Edvardsson N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth. 1997;78(5): 507-514.
22. Mio Y, Fukuda N, Kusakari Y, Amaki Y, Tanifuji Y, Kurihara S. Comparative effects of bupivacaine and ropivacaine on intracellular calcium transients and tension in ferret ventricular muscle. Anesthesiology. 2004;101(4):888-894.
23. 2+ in rat ventricular muscle. Anesthesiology. 2002;97(5):1168-1177.
24. Maughan DW. Kinetics and energetics of the crossbridge cycle. Heart Fail Rev. 2005;10(3):175-185.
25. Sztark F, Malgat M, Dabadie P, Mazat JP. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology. 1998;88(5):1340-1349.
26. Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edelman G, Hoppel CL. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology. 2000;92(2):523-528.
27. Iida H, Watanabe Y, Dohi S, Ishiyama T. Direct effects of ropivacaine and bupivacaine on spinal pial vessels in canine. Assessment with closed spinal window technique. Anesthesiology. 1997;87(1): 75-81.
28. Bariskaner H, Tuncer S, Taner A, Dogan N. Effects of bupivacaine and ropivacaine on the isolated human umbilical artery. Int J Obstet Anesth. 2003;12(4):261-265.
29. Rossner KL, Natke E, Liu-Barnett M, Freese KJ. A proposed mechanism of bupivacaine-induced contraction of human umbilical artery smooth muscle cells. Int J Obstet Anesth. 1999;8(1):24-29.
30. Monuszko E, Halevy S, Freese K, Liu-Barnett M, Altura B. Vasoactive actions of local anaesthetics on human isolated umbilical veins and arteries. Br J Pharmacol. 1989;97(2):319-328.
31. 2+ concentration in rat aortic smooth muscle. Acta Anaesthesiol Scand. 2007;51(9):1155-1160.
32. Hahnenkamp K, Nollet J, Strumper D, Halene T, Rathman P, Mortier E, et al. Bupivacaine inhibits thromboxane A2-induced vasoconstriction in rat thoracic aorta. Anesth Analg. 2004;99(1):97-102.
33. Newton DJ, McLeod GA, Khan F, Belch JJ. Vasoactive characteristics of bupivacaine and levobupivacaine with and without adjuvant epinephrine in peripheral human skin. Br J Anaesth. 2005;94(5): 662-667.
34. Newton DJ, McLeod GA, Khan F, Belch JJ. Mechanisms influencing the vasoactive effects of lidocaine in human skin. Anesthesia. 2007;62(2):146-150.
35. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or Resuscitation with a Lipid Infusion Shifts the Dose-Response to Bupivacaine-induced Asystole in Rats. Anesthesiology. 1998;88(4):1071-1075.
36. Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion. Anesthesia. 2006;61(8):800-801.
37. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology. 2006; 105(1):217-218.
38. Warren JA, Thoma RB, Georgescu A, Shah SJ. Intravenous lipid infusion in the successful resuscitation of local anesthetic-induced cardiovascular collapse after supraclavicular brachial plexus block. Anesth Analg. 2008;106(5):1578-1580.
39. Litz RJ, Roessel T, Heller AR, Stehr SN. Reversal of central nervous system and cardiac toxicity after local anesthetic intoxication by lipid emulsion injection. Anesth Analg. 2008;106(5):1575-1577.
40. Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008;51(4):412-145, 145 e1.
41. Weinberg G. Lipid rescue resuscitation from local anaesthetic cardiac toxicity. Toxicol Rev. 2006;25(3):139-145.
42. Weinberg GL. Lipid infusion therapy: translation to clinical practice. Anesth Analg. 2008;106(5):1340-1342.
43. Weinberg G. Lipid infusion resuscitation for local anesthetic toxicity: proof of clinical efficacy. Anesthesiology. 2006;105(1):7-8.
44. Ludot H, Tharin JY, Belouadah M, Mazoit JX, Malinovsky JM. Successful resuscitation after ropivacaine and lidocaine-induced ventricular arrhythmia following posterior lumbar plexus block in a child. Anesth Analg. 2008;106(5):1572-1574.
45. Mazoit JX, Le Guen R, Beloeil H, Benhamou D. Binding of long-lasting local anesthetics to lipid emulsions. Anesthesiology. 2009;110(2):380-386.
46. Turner-Lawrence DE, Kerns Ii W. Intravenous fat emulsion: a potential novel antidote. J Med Toxicol. 2008;4(2):109-114.
47. Edelman LB, Ripper R, Kelly K, Di Gregorio G, Weinberg GL. Metabolic context affects hemodynamic response to bupivacaine in the isolated rat heart. Chem Biol Interact. 2008 10;172(1):48-53.
48. Brull SJ. Lipid emulsion for the treatment of local anesthetic toxicity: patient safety implications. Anesth Analg. 2008;106(5): 1337-1339.
49. Hiller DB, Gregorio GD, Ripper R, Kelly K, Massad M, Edelman L, et al. Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology. 2009;111(3):498-505.
50. Mayr VD, Mitterschiffthaler L, Neurauter A, Gritsch C, Wenzel V, Muller T, et al. A comparison of the combination of epinephrine and vasopressin with lipid emulsion in a porcine model of asphyxial cardiac arrest after intravenous injection of bupivacaine. Anesth Analg. 2008;106(5):1566-1571.
51. Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28(3):198-202.
52. Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med. 2007;49(2): 178-185, 185 e1-e4.
53. Harvey MG, Cave GR. Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. J Med Toxicol. 2008;4(2):71-76.
54. Weinberg GL, Ripper R, Murphy P, Edelman LB, Hoffman W, Strichartz G, et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med. 2006;31(4):296-303.